Resourcing real-world evidence (RWE) is becoming an increasingly important asset in developing novel therapies for cancer. In this article, an overview of the benefits and challenges of using these data is provided. Through several case examples we highlight future applications and potential.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.trecan.2020.08.006 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!